NDC 49401-088-01 - BENLYSTA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49401-088
- Requested NDC
- 49401-088-01
- Package NDCs from labels
- 49401-088-42, 49401-088-47, 49401-088-50, 49401-088-01, 49401-088-35, 49401-088-02, 49401-088-61
- Manufacturer
- GlaxoSmithKline LLC
- Effective date
- 2026-08-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BENLYSTA - GlaxoSmithKline LLC | GlaxoSmithKline LLC | 2026-08-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49401-088-01 | BENLYSTA | 1 mL in 1 SYRINGE | SOLUTION | 1 | 37 | |
| 49401-088-02 | BENLYSTA | 1 in 1 CARTON | SOLUTION | 1 | 37 | |
| 49401-088-35 | BENLYSTA | 4 in 1 CARTON | SOLUTION | 4 | 37 | |
| 49401-088-42 | BENLYSTA | 1 mL in 1 SYRINGE | SOLUTION | 1 | 37 | |
| 49401-088-47 | BENLYSTA | 4 in 1 CARTON | SOLUTION | 4 | 37 | |
| 49401-088-50 | BENLYSTA | 1 in 1 CARTON | SOLUTION | 1 | 37 | |
| 49401-088-61 | BENLYSTA | 1 mL in 1 SYRINGE | SOLUTION | 1 | 37 | |
| 49401-088-61 | BENLYSTA | 1 in 1 CARTON | SOLUTION | 1 | 37 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49401-088 | BENLYSTA (BELIMUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION BENLYSTA (BELIMUMAB) SOLUTION [GLAXOSMITHKLINE LLC] | 34 | Current NDC, Legacy NDC, 8 package rows | 20241220_2fa3c528-1777-4628-8a55-a69dae2381a3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49401-088-01 | ML - Milliliter | 49401-088 | bcf92992-9bad-464c-9d35-ac1a5039ded2 | 1 | 2017-08-11 |
| 49401-088-35 | ML - Milliliter | 49401-088 | 032d8042-004e-4b1c-ba71-6da76b6a2968 | 1 | 2017-08-11 |
| 49401-088-42 | ML - Milliliter | 49401-088 | d29db4cf-ac8e-4023-83e0-f45c6c8669f5 | 1 | 2017-08-11 |
| 49401-088-47 | ML - Milliliter | 49401-088 | 1a653d99-ed2e-487f-9d87-c06f594b4217 | 1 | 2017-08-11 |
| 49401-088-61 | ML - Milliliter | 49401-088 | 81ce2c39-0bcf-4952-b030-94e59fee1108 | 1 | 2022-05-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BELIMUMAB | ACTIVE INGREDIENT | 73B0K5S26A | BENLYSTA (BELIMUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HUMAN GENOME SCIENCES, INC.] | 12 | |
| BELIMUMAB | ACTIVE MOIETY | 73B0K5S26A | BENLYSTA (BELIMUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HUMAN GENOME SCIENCES, INC.] | 12 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | BENLYSTA (BELIMUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HUMAN GENOME SCIENCES, INC.] | 12 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | BENLYSTA (BELIMUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HUMAN GENOME SCIENCES, INC.] | 12 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | BENLYSTA (BELIMUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HUMAN GENOME SCIENCES, INC.] | 12 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | BENLYSTA (BELIMUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HUMAN GENOME SCIENCES, INC.] | 12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| D-99 | ATROPA BELLADONNA, NITROGLYCERIN, LACTIC ACID, UNSPECIFIED FORM, SCROPHULARIA NODOSA, ALOE, RADIUM BROMIDE, POTASSIUM IODIDE, SUS SCROFA BONE MARROW, ZINC, AND CITRIC ACID MONOHYDRATE | DNA Labs, Inc. | dd9c0226-35ea-445a-a570-1ec35551f68d | 2025-01-13 | Warnings | 2968PHW8QP |
| D-97 | ALUMINUM OXIDE, SILVER, SILVER NITRATE, ARSENIC TRIOXIDE, MERCURIUS SOLUBILIS, CALOMEL, MERCURIC IODIDE, LEAD, LEAD IODIDE, CHELIDONIUM MAJUS, ZINC, SOLIDAGO VIRGAUREA FLOWERING TOP, AND CITRIC ACID MONOHYDRATE | DNA Labs, Inc. | b2079abb-786c-4f92-8d49-5606c77f7d72 | 2025-01-13 | Warnings | 2968PHW8QP |
| D-112 | LACHESIS MUTA VENOM, SILICON DIOXIDE, SODIUM CHLORIDE, RANUNCULUS BULBOSUS, ACONITUM NAPELLUS, ACTIVATED CHARCOAL, NITROGLYCERIN, OYSTER SHELL CALCIUM CARBONATE, CRUDE, ANEMONE PRATENSIS, PLANTAGO MAJOR, ARSENIC TRIOXIDE, AND MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE | DNA Labs, Inc. | 8d517ef2-3a1e-4393-9452-a4cd0f0a3bca | 2025-01-13 | Warnings | 451W47IQ8X |
| D-65 | ARSENIC TRIOXIDE, BERBERIS AQUIFOLIUM ROOT BARK, OYSTER SHELL CALCIUM CARBONATE, CRUDE, GRAPHITE, CENTELLA ASIATICA, AND SODIUM CHLORIDE | DNA Labs, Inc. | 94d4b66a-f995-4516-bdcf-2152c2a624dd | 2025-01-13 | Warnings | 451W47IQ8X |
| D-88 | COCCULUS INDICUS, NATRUM MURIATICUM, HELONIAS DIOICA, CALCAREA PHOSPHORICUM, IGNATIA AMARA, MAGNESIA PHOSPHORICUM, CIMICIFUGA RACEMOSA, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS, SEPIA, KALIUM PHOSPHORICUM, ZINCUM METALLICUM, PITUITARY, ADRENAL, OVARIAN | DNA Labs, Inc. | 1eefff9c-d86c-44ef-b968-9a8c5a9c5403 | 2025-01-13 | Warnings | 451W47IQ8X |
| D-133 | CALCIUM FLUORIDE, SILICON DIOXIDE, TRIBASIC CALCIUM PHOSPHATE, CALCIUM SULFATE ANHYDROUS, FERROSOFERRIC PHOSPHATE, POTASSIUM CHLORIDE, DIBASIC POTASSIUM PHOSPHATE, POTASSIUM SULFATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM CHLORIDE, AND SODIUM SULFATE | DNA Labs, Inc. | a250b7e9-7fd2-4cb0-82f3-baa089d17441 | 2025-01-13 | Warnings | 451W47IQ8X |
| Premixed saline packets | SODIUM CHLORIDE, SODIUM BICARBONATE | Shenzhen Kerui lntl Trading Co., Ltd | 0d11e07b-c137-6efc-e063-6394a90a6bba | 2025-01-09 | Warnings | 451W47IQ8X |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | AvPAK | fe070e2e-3e72-fb84-e053-6294a90afd88 | 2025-01-09 | Adverse reactions | 1Q73Q2JULR |
| A-5 | SUCROSE | DNA Labs, Inc. | 8e63f697-26c1-4518-acd3-5ea72cfa27f7 | 2025-01-09 | Warnings | C151H8M554 |
| A-36 | BOS TAURUS ADRENAL GLAND, AGRIMONIA EUPATORIA, BELLIS PERENNIS, CAMPHOR (NATURAL), MATRICARIA CHAMOMILLA, EQUISETUM HYEMALE, FRAXINUS AMERICANA BARK, FORMICA RUFA, HISTAMINE DIHYDROCHLORIDE, IODINE, POTASSIUM DICHROMATE, CANIS LUPUS FAMILIARIS MILK, SODIUM CHLORIDE, ANEMONE PULSATILLA, SALIX NIGRA BARK, AND TOBACCO LEAF | DNA Labs, Inc. | 161c4738-9ead-4687-9f5a-029d5a496e07 | 2025-01-09 | Warnings | 451W47IQ8X |
| AM-11 | ARNICA MONTANA, SODIUM CHLORIDE, AND APIS MELLIFERA | DNA Labs, Inc. | c072811b-6259-4b22-b364-50369dc68fb0 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-13 | CEANOTHUS AMERICANUS LEAF, URTICA URENS, SODIUM CHLORIDE, LACHESIS MUTA WHOLE, CINCHONA OFFICINALIS BARK, LYCOPODIUM CLAVATUM WHOLE, FERRIC CHLORIDE HEXAHYDRATE, AND SUS SCROFA SPLEEN | DNA Labs, Inc. | 146c5465-bcd9-4057-8975-dc1088b9971b | 2025-01-09 | Warnings | 451W47IQ8X |
| N-10 | SODIUM CHLORIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, SEPIA OFFICINALIS JUICE, IODINE, LYCOPODIUM CLAVATUM WHOLE, AND BOS TAURUS PITUITARY GLAND, POSTERIOR | DNA Labs, Inc. | 264d8093-70f3-43a5-bfc4-b719bb3e45e6 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-16 | MGO ENERGIZER | DNA Labs, Inc. | 8292b900-86c1-47ea-81da-b587439c7664 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-21 | CALCIUM FLUORIDE, SILICON DIOXIDE, EUPHRASIA STRICTA, RUTA GRAVEOLENS WHOLE, GELSEMIUM SEMPERVIRENS WHOLE, PHYSOSTIGMA VENENOSUM WHOLE, ANEMONE PULSATILLA, SODIUM CHLORIDE, AND SUS SCROFA EYE | DNA Labs, Inc. | 89967941-c4ee-4598-a66d-8a93d69a4d65 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-14 | FUCUS VESICULOSUS, SODIUM CHLORIDE, LYCOPUS VIRGINICUS, SPONGIA OFFICINALIS SKELETON, ROASTED, POTASSIUM IODIDE, CALCIUM IODIDE, THYROID, UNSPECIFIED, BOS TAURUS ADRENAL GLAND, BOS TAURUS PITUITARY GLAND, POSTERIOR, BOS TAURUS THYMUS, AND SUS SCROFA SPLEEN | DNA Labs, Inc. | 3d64739c-5d61-4e88-8612-d5f6994f1c3c | 2025-01-09 | Warnings | 451W47IQ8X |
| N-24 | METABOLIN | DNA Labs, Inc. | 559fca2b-1093-4bdf-be70-c453f87002c3 | 2025-01-09 | Warnings | 451W47IQ8X |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 8dfb05c0-77e8-2fa1-e053-2a95a90a3d33 | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 998a2a47-5c79-2efd-e053-2995a90a8fac | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 7da788fc-3481-527f-e053-2a91aa0af6ac | 2025-01-08 | Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.